HK40052182B - Hexahydroimidazopyridopyrimidinone, analogs and salts thereof and their use in therapy - Google Patents

Hexahydroimidazopyridopyrimidinone, analogs and salts thereof and their use in therapy

Info

Publication number
HK40052182B
HK40052182B HK42021040942.1A HK42021040942A HK40052182B HK 40052182 B HK40052182 B HK 40052182B HK 42021040942 A HK42021040942 A HK 42021040942A HK 40052182 B HK40052182 B HK 40052182B
Authority
HK
Hong Kong
Prior art keywords
hexahydroimidazopyridopyrimidinone
analogs
therapy
salts
Prior art date
Application number
HK42021040942.1A
Other languages
Chinese (zh)
Other versions
HK40052182A (en
Inventor
M‧斯托格努
J‧E‧阿朗
R‧S‧波托夫
B‧R‧纳拉罕楚
G‧L‧奥尔森
Y‧孙
Original Assignee
昂克希尔迪克斯有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 昂克希尔迪克斯有限公司 filed Critical 昂克希尔迪克斯有限公司
Publication of HK40052182A publication Critical patent/HK40052182A/en
Publication of HK40052182B publication Critical patent/HK40052182B/en

Links

HK42021040942.1A 2015-01-30 2021-10-21 Hexahydroimidazopyridopyrimidinone, analogs and salts thereof and their use in therapy HK40052182B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US62/109,737 2015-01-30
US62/148,844 2015-04-17
US62/233,757 2015-09-28

Publications (2)

Publication Number Publication Date
HK40052182A HK40052182A (en) 2022-01-21
HK40052182B true HK40052182B (en) 2025-09-05

Family

ID=

Similar Documents

Publication Publication Date Title
IL249370A0 (en) Fap-activated therapeutic agents, and uses related thereto
EP3137168A4 (en) Substituted 4-phenylpiperidines, their preparation and use
EP3207162A4 (en) Combination therapy for use in cancer therapy
GB201511382D0 (en) Novel compounds and their use in therapy
EP3188721A4 (en) Human therapeutic agents
GB201408673D0 (en) Medicaments,uses and methods
GB201502412D0 (en) Therapeutic use
IL248855A0 (en) (s)-pirlindole or its pharmaceutically acceptable salts for use in medicine
EP3302530A4 (en) Cdh26 based therapeutic agents and their use
GB201406172D0 (en) Therapy and pharmaceutical composition
IL249122A0 (en) Imidazol- or 1,2,4-triazol-derivatives and their use
EP3223817A4 (en) Substantially pure vemurafenib and its salts
ME03727B (en) Salt substitute composition, preparation and use thereof
PL3386988T3 (en) Novel dihydropyranopyrimidinone derivatives, and use thereof
PT3325478T (en) New therapeutic compound and use in therapy
GB201506786D0 (en) Therapeutic use
EP3204003A4 (en) Selenosugars and therapeutic uses thereof
HK40052182B (en) Hexahydroimidazopyridopyrimidinone, analogs and salts thereof and their use in therapy
EP3530738A4 (en) Tnf- -binding aptamer, and therapeutic use for same
HK40112156A (en) Medicaments, uses and methods
IL237283A0 (en) Dldh, derivatives thereof and formulations comprising same for use in medicine
IL251930A0 (en) Benzylhydroxyde derivatives, preparation thereof and therapeutic use thereof
GB2553684B (en) Ethynylxanthines, preparation and use for cancer treatment
GB201516494D0 (en) New therapeutic use
GB201409978D0 (en) Novel compounds and their use in therapy